Pronađeno: 1-5 / 5 radova

Autori: Mrsic-Krmpotic Zrinka

>> Filter: Samo Article i Review

Naslov FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article)
Autori Brodowicz Thomas  Ciuleanu Tudor E  Radosavljevic Davorin Z  Shacham-Shmueli Einat  Vrbanec Damir  Plate Signe  Mrsic-Krmpotic Zrinka  Dank M  Purkalne Gunta  Messinger D  Zielinski Christoph 
Info ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777
Projekat CECOG
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract)
Autori Ciuleanu Tudor E  Nikolic Vladimir  Shmueli E  Vrbanec Damir  Plate Signe  Mrsic-Krmpotic Zrinka  Dank M  Purkalne Gunta  Brodowicz Thomas  Zielinski Christoph 
Info JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract)
Autori Ciuleanu Tudor E  Nikolic Vladimir  Shmueli E  Vrbanec Damir  Plate Signe  Mrsic-Krmpotic Zrinka  Dank Magdolna  Purkalne Gunta  Brodowicz Thomas  Zielinski Christoph 
Info JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Cetuximab Weekly (Q1W) Versus Every Two Weeks (Q2W) Plus Folfox4 as First-line Therapy in Patients (PTS) with Kras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) (Meeting Abstract)
Autori Ciuleanu Tudor E  Nikolic Vladimir  Shacham-Shmueli Einat  Vrbanec Damir  Plate Signe  Mrsic-Krmpotic Zrinka  Kahan Zsuzsanna  Purkalne Gunta  Brodowicz Thomas  Zielinski Christoph 
Info ANNALS OF ONCOLOGY, (2011), vol. 22 br. , Suppl. Suppl. 5, str. v22-v22
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial (Article)
Autori Jassem Jacek  Pienkowski Tadeusz  Pluzanska Anna  Jelic Svetislav B  Gorbunova Vera  Mrsic-Krmpotic Zrinka  Berzins Juris  Nagykalnai Thomas  Wigler N  Renard J  Munier Stephane  Weil C 
Info JOURNAL OF CLINICAL ONCOLOGY, (2001), vol. 19 br. 6, str. 1707-1715
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX